Block Admission Application

RNS Number : 0076H

Futura Medical PLC

20 May 2011

 



For immediate release

20 May 2011

Futura Medical plc

("Futura" or "the Company")

Block Admission Application

Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, announces that an application has been made to the London Stock Exchange for the block admission of a total of 2,335,000 ordinary shares of 0.2p pence each to be admitted to trading on AIM. The block listing application covers already awarded options and the shares may be issued pursuant to the share option schemes detailed below:

Option Plan	No. of Shares in Block Admission
Futura Medical plc Unapproved  Share Option Scheme	814,424
Futura Medical plc EMI Share Option Scheme	1,520,576

All shares expected to be admitted pursuant to the above applications shall rank pari passu with the existing issued ordinary shares of the Company. It is expected that admission will become effective on 25 May 2011.

For any further information please contact:

Futura Medical plc
James Barder, Chief Executive	Tel: [phone]
mail to: [e-mail]	www.futuramedical.com
Nomura Code Securities Limited
Phil Walker / Giles Balleny	Tel:[phone]
For media enquiries please contact:
Buchanan Communications
Mark Court / Jessica Fontaine	Tel: [phone]

Notes to Editors

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com

 

END

 

 

LISBBLFLFEFXBBD